Skip to main content
ISTH 2024 Main banner
Back

Massoud Mirshahi, M. D., Ph. D

Team Director
CAP-Paris Tech., INSERM U1275, Université Paris Cité, Hôpital Lariboisière
Paris, Ile-de-France, France

Massoud MIRSHAHI: M. D., Ph.D, French nationality, Researcher in CNRS (1986- p), Professor of oncology (2009-p), Academician (2002) (FM), Co-head of Regenerative Medicine in Avicenna University, Dushanbe (Tajikistan 2009-p), Several patents and licenses for industrial exploitation, several scientist awards such as Immunopathology of the Eye, Tokyo Japan, 1986, American College of Toxicology » 2002, Pennsylvania, USA, Prize of “Institut de France” (Prix Dalloz), 2006, Paris, south Korea cancer institute 2017, over 200 international scientific publications, 290 congress communications. Editor en chef for several scientific journal, Reviewer in several International Journals such as in Oncology, immunology and Ophthalmology fields. Member of several International Academic Associations, Thesis director of more than 20 thesis, as well as several postgraduate students, Masters, and postdoctoral students. Obtaining of research grants from several local associations, French or foreign industries and foundations. Main research specialty is: cancerology, immunology, fibrinolysis, thrombosis and coagulation, ocular immunopathology, principal activity: role of the microenvironment in cancer cell proliferation, metastasis and resistance to therapy. Discovery of a tumor micro-environmental cell (named Hospicell) protecting cancer cells from chemotherapy by different mechanisms. Stem cell therapy for heart regenerative medicine and target therapy in cancer disease.

Key words: Arrestin, Plasminogen Activators, Fibrin-Fibrinogen, Thrombosis, D-Dimer, Autoimmune-Disease, Mineralocorticoid Receptor (MCR), Epithelial Sodium Channel (Enac), Ophthalmology (Retina And Cornea), Cancer, Angiogenesis, Chemoresistance, Leukemia, Bone Marrow Stromal Cells, Hospicell, Biomaterial, Nanoparticle, Radio-Frequency Plasma, Mesenchymal Cells, Stem Cells, Regenerative Medicine, Carcinomatosis. Personalized Medecine. Cancer and Thrombosis, Immunology of Cancer, HLA-G.

Presentation(s):